Clinical Trial for cats with congestive heart failure due to cardiomyopathy
CALL FOR CASES - DO YOU CARE ABOUT CATS?
Clinical Trial for cats with congestive heart failure due to cardiomyopathy
We are one of a number of UK, European and USA centres involved in a clinical trial testing a novel drug for congestive heart failure in cats due to cardiomyopathy (most commonly this will be due to hypertrophic cardiomyopathy (HCM)). The cat must be stable with well controlled congestive heart failure on permitted medication (furosemide or torasemide, clopidogrel and possibly also an ACE-inhibitor). The costs of the screening visit will be covered. If the cat meets the inclusion criteria and the owner gives their informed consent for the cat to be permitted, the costs of these visits will be covered by the sponsor company. However, if the cat requires emergency referral for stabilisation of congestive heart failure, these costs prior to becoming stable will be normally charged to the client.
If you are a vet and think that you have a suitable case, please call the cardiology service for more information and to discuss your patient with the cardiology service.
If you are an owner who has a cat with heart failure, please ask your primary care vet to contact us to discuss the possibility of being included in this study.
We really need more evidence about how best to treat cats with cardiomyopathy and congestive heart failure and this study will help gather that.